Reference
Yang Y, et al. A case of the third-line treatment of lung adenocarcinoma using nivolumab combined with anlotinib. Pharmazie 76: 338-340, No. 7, Jul 2021. Available from: URL: http://doi.org/10.1691/ph.2021.1420
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1892, 42 (2022). https://doi.org/10.1007/s40278-022-09584-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-09584-y